Table 5.
Multivariate COX regression analysis of non-fatal stroke
| Univariate | Multivariate | |||
|---|---|---|---|---|
| HR (95%CI) | P value | Adjusted HR (95%CI) | P value | |
| Age, y | 1.02 (0.99, 1.05) | NS | 0.99 (0.97, 1.02) | NS |
| ACEI/ARB(-) | 1.82 (1.13, 2.96) | < 0.05 | 1.72 (1.05, 2.84) | < 0.05 |
| Beta-blocker before admission | 0.54 (0.29, 1.01) | NS | 0.56 (0.30, 1.06) | NS |
| Previous stroke | 4.00 (2.52, 6.35) | < 0.001 | 3.70 (2.29, 5.96) | < 0.001 |
| Hemoglobin, g/L | 0.98 (0.96, 0.99) | < 0.05 | 0.99 (0.97, 1.01) | NS |
| AMI at admission | 2.10 (1.32, 3.35) | < 0.05 | 1.07 (0.61, 1.86) | NS |
| LVEF, % | 0.95 (0.93, 0.97) | < 0.001 | 0.96 (0.94, 0.99) | < 0.05 |
| Involved vessel | 1.79 (1.28, 2.49) | < 0.05 | 1.52 (1.08, 2.14) | < 0.05 |
| In-hospital treatment | ||||
| ACEI/ARB | 0.72 (0.46, 1.14) | NS | 0.85 (0.52, 1.38) | NS |
| Antiplatelet agents | 0.34 (0.16, 0.75) | <0.05 | 0.49 (0.19, 1.25) | NS |
| Statins | 0.43 (0.24, 0.76) | <0.05 | 0.58 (0.30, 1.11) | NS |
ACEI/ARB(-) no Angiotensin-converting enzyme inhibitor/Angiotensin receptor blocker therapy before admission, AMI acute myocardial infarction, LVEF left ventricular ejection fraction; NS Non-significant